Clinical trials

The European Union Clinical Trials Register allows you to search for protocol and results information on:

interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC

clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).

The EU Clinical Trials Register currently displays 44336 clinical trials with a EudraCT protocol, of which 7366 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).

Examples: Cancer AND drug name. Pneumonia AND sponsor name.
How to search [pdf]

Advanced Search:

Search tools

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Trials with a EudraCT protocol (10,988)
Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)

10,988 result(s) found. Displaying page 273 of 550.

EudraCT Number: 2005-005980-27

Sponsor Protocol Number: NK-104-308

Start Date*: 2006-05-04

Sponsor Name:Kowa Research Europe Ltd.

Full Title: OPEN-LABEL, LONG-TERM ( ≥ 1 YEAR) EXTENSION STUDY OF PITAVASTATIN 2 MG AND 4 MG QD IN ELDERLY PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIA

Medical condition: Patients with Primary Hypercholesterolemia or Combined Dyslipidemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10020604		LLT

Population Age: Elderly

Gender: Male, Female

Trial protocol: GB (Completed) DK (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2005-005856-42	Sponsor Protocol Number: NKT102553	Start Date*: 2006-03-29
Sponsor Name:GlaxoSmithKline Research and Development Ltd
Full Title: A Phase III, Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of 50 mg Oral Dosing with the Neurokinin-1 Receptor Antagonist GW679769 for the Preventi...
Medical condition: Postoperative Nausea and Vomiting (PONV)
Disease:
Population Age: Adults, Elderly		Gender: Female
Trial protocol: GB (Completed) HU (Completed) DE (Completed) IE (Completed)
Trial results: View results

EudraCT Number: 2004-004707-38

Sponsor Protocol Number: CCR 3065

Start Date*: 2005-04-08

Sponsor Name:Royal Marsden NHS Trust

Full Title: A multicentre randomised phase II clinical trial comparing oxaliplatin (Eloxatin), capecitabine (Xeloda) and pre-operative radiotherapy with or without cetuximab followed by total mesorectal excisi...

Medical condition: High risk operable rectal adenocarcinoma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	13.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10038038	Rectal cancer	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) ES (Ongoing) SE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-001246-13	Sponsor Protocol Number: TV3/001/06	Start Date*: 2007-01-22
Sponsor Name:Oxford BioMedica UK Ltd.
Full Title: Estudio internacional, aleatorizado, doble ciego, controlado con placebo y de grupos paralelos, para investigar si Trovax, añadido al tratamiento estándar de primera linea, prolonga la supervivenci...
Medical condition: Locally advanced or metastatic renal clear cell adenocarcinoma
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: ES (Completed) DE (Prematurely Ended) GB (Completed)
Trial results: View results

EudraCT Number: 2006-003107-39

Sponsor Protocol Number: 0524A-023

Start Date*: Information not available in EudraCT

Sponsor Name:Merck & Co

Full Title: A Worldwide, Multicenter, Double-Blind, Randomized, Parallel Study to Evaluate the Efficacy of MK-0524 to Improve Tolerability of Extended Release Niacin

Medical condition: Hypercholesterolemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10020604	Hypercholesterolemia	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) GB (Completed) AT (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2006-001472-20

Sponsor Protocol Number: LEO19123-C21

Start Date*: 2006-08-15

Sponsor Name:LEO Pharma A/S

Full Title: LEO19123 Cream in the Treatment of Atopic Dermatitis A Phase II, proof of concept study, testing once daily use of two dose-combinations of LEO19123 cream (calcipotriol and LEO80122) in the treatm...

Medical condition: Atopic dermatitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10003639	Atopic dermatitis	LLT

Population Age: Adults

Gender: Male

Trial protocol: DK (Completed) FI (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2006-004303-19

Sponsor Protocol Number: BSX - 001

Start Date*: 2007-04-25

Sponsor Name:Cerimon Pharmaceuticals, Inc.

Full Title: A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of Basiliximab, with Concomitant Corticosteroids, in Steroid-Refractory Ulc...

Medical condition: Steroid-refractory ulcerative colitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10009900	Colitis ulcerative	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) BE (Completed) CZ (Prematurely Ended) SK (Completed)

Trial results: (No results available)

EudraCT Number: 2006-001859-35

Sponsor Protocol Number: cro632

Start Date*: 2007-04-13

Sponsor Name:Imperial College London

Full Title: Abatacept in ANCA associated vasculitis: ABAVAS

Medical condition: Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	8.1		10050894	Anti-neutrophil cytoplasmic antibody positive vasculitis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) NL (Prematurely Ended)

Trial results: View results

EudraCT Number: 2007-000042-12

Sponsor Protocol Number: A7881004

Start Date*: 2007-06-05

Sponsor Name:Pfizer Ltd. Ramsgate Road, Sandwich, Kent, UK

Full Title: A PHASE IIA RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO AND ACTIVE CONTROLLED 5-WAY CROSS-OVER TRIAL TO EXAMINE THE BRONCHODILATOR EFFECTS OF PF-610,355 AND TO TEST FOR SUPERIORITY VERSUS PLACE...

Medical condition: Asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10003553	Asthma	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Completed) SE (Completed) DE (Completed)

Trial results: View results

EudraCT Number: 2007-002145-21

Sponsor Protocol Number: 2007003

Start Date*: 2007-12-21

Sponsor Name:Procter & Gamble Pharmaceuticals

Full Title: A Phase II, Randomized, Placebo-controlled Study of ATI-7505 in Patients with Chronic Idiopathic Constipation

Medical condition: Chronic Idiopathic Constipation

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10063582	Constipation chronic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) BE (Completed) GB (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2007-003997-24

Sponsor Protocol Number: LTS 6047

Start Date*: 2008-07-08

Sponsor Name:Sanofi-Aventis recherche & développement

Full Title: Long-term extension of the multinational, double-blind, placebo controlled study PDY6045 and PDY6046 to document the safety of teriflunomide when added to treatment with interferon-beta or glatiram...

Medical condition: Multiple Sclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	12.1		10028245	Multiple sclerosis	LLT

Population Age: Adults

Gender: Male, Female

Trial protocol: GB (Completed) AT (Completed) ES (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2007-006276-11

Sponsor Protocol Number: VR496/005

Start Date*: 2008-09-01

Sponsor Name:Vectura Limited

Full Title: A Phase I/II randomised, placebo-controlled, double blind trial to assess the safety, tolerability, pharmacodynamics and exploratory efficacy of heparin 25 mg inhalation powder in patients with Cys...

Medical condition: Cystic Fibrosis

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10011763	Cystic fibrosis lung	LLT

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: GB (Completed) IE (Completed) PL (Completed) IT (Completed)

Trial results: View results

EudraCT Number: 2007-004888-22	Sponsor Protocol Number: CHCD122A2103	Start Date*: 2008-03-27
Sponsor Name:Novartis Pharma AG
Full Title: A phase IA/II, multi-center, open-label study of HCD122 administered intravenously once weekly for four weeks in adult patients with advanced non-Hodgkin's or Hodgkin's lymphoma who have progressed...
Medical condition: Advanced non Hodgkin's or Hodgkin's lymphoma
Disease:
Population Age: Adults, Elderly		Gender: Male, Female
Trial protocol: BE (Completed) DE (Completed) FR (Completed) GB (Completed)
Trial results: View results

EudraCT Number: 2007-007000-15

Sponsor Protocol Number: CICL670A2209

Start Date*: 2009-01-19

Sponsor Name:Novartis Pharma Services AG

Full Title: A randomized, double-blind, placebo-controlled, phase II study to evaluate efficacy and safety of deferasirox in nontransfusion-dependent thalassemia patients with iron overload (THALASSA)

Medical condition: Chronic iron overload in patients with non-transfusion-dependent thalassemia

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10043389	Thalassaemic disorders	HLT

Population Age: Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed) IT (Completed) GR (Completed)

Trial results: View results

EudraCT Number: 2008-002096-27

Sponsor Protocol Number: CFTY720D2309

Start Date*: 2008-09-10

Sponsor Name:Novartis Pharma Services AG

Full Title: A 24-month double-blind, randomized, multicenter, placebocontrolled, parallel-group study comparing the efficacy and safety of 0.5 mg and 1.25 mg fingolimod (FTY720) administered orally once daily ...

Medical condition: Relapsing-remitting multiple sclerosis.

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	13.1	10029205 - Nervous system disorders	10063399	Relapsing-remitting multiple sclerosis	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: PL (Completed) AT (Completed) LT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2008-001413-14

Sponsor Protocol Number: 205.416

Start Date*: 2008-08-20

Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG

Full Title: A Phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat ® inhaler (5 μg/day) over 48 ...

Medical condition: Patients with severe persistent asthma who are still symptomatic despite being treated with high-dose inhaled corticosteroids and long-acting beta2-agonists. Additional asthma treatments are allowe...

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10049106	Asthma chronic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) NL (Completed) IT (Completed) GB (Completed)

Trial results: View results

EudraCT Number: 2008-000349-68

Sponsor Protocol Number: B0451004

Start Date*: 2008-11-05

Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York NY10017

Full Title: A PHASE II PROSPECTIVE, RANDOMIZED, MULTI-CENTER, DIABETIC MACULAR EDEMA DOSE RANGING, COMPARATOR STUDY EVALUATING THE EFFICACY AND SAFETY OF PF-04523655 VERSUS LASER THERAPY (DEGAS)

Medical condition: Diabetic Macular Edema

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10057934	Diabetic macular edema	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Prematurely Ended) DK (Prematurely Ended) IT (Prematurely Ended) DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2007-006545-41

Sponsor Protocol Number: PPD/2007/AER 001 DPI/2b

Start Date*: 2009-03-20

Sponsor Name:Aerovance, Inc

Full Title: A PHASE IIB STUDY TO INVESTIGATE THE TREATMENT-SPARING EFFECTS OF AEROVANT™ (AER 001 INHALATION POWDER) IN ASTHMA PATIENTS NOT FULLY CONTROLLED ON CURRENT THERAPY

Medical condition: moderate persistent to severe persistent asthma

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10003553	Asthma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) GB (Completed) PL (Completed)

Trial results: (No results available)

EudraCT Number: 2008-006252-21

Sponsor Protocol Number: 3160A6-2207-WW

Start Date*: 2009-05-28

Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc

Full Title: A Phase 2, Randomized, Open-label Study of Bosutinib Administered in Combination With Letrozole Versus Letrozole Alone as First Line Therapy in Post-Menopausal Women With Locally Advanced or Metast...

Medical condition: Locally advanced or metastatic ER+/PgR+/erbB2-breast cancer in post-menopausal women

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	9.1		10027475	Metastatic breast cancer	LLT

Population Age: Adults

Gender: Female

Trial protocol: HU (Completed) BE (Completed) GB (Prematurely Ended) DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2009-015386-30

Sponsor Protocol Number: GLP108486

Start Date*: 2010-01-29

Sponsor Name:GlaxoSmithKline LLC

Full Title: A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with...

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
Disease:	14.0	10027433 - Metabolism and nutrition disorders	10045242	Type II diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed) FR (Completed) GB (Completed) ES (Completed)

Trial results: View results

Subscribe to this Search
To subscribe to the RSS feed for this search click here

. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.

Download Options:
Number of Trials to download:

Download Content:

Download Format:


Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.

Query did not match any studies.

For support, Contact us.

The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

European Medicines Agency © 1995-Tue May 20 11:04:54 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA